Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.
(Studio: Dan Rather) Report introduced.
(New York: John Roberts) New possible treatments for cancer, angiostatin, discussed; method of fighting cancer growth explained; scenes shown in Rockville, MD, of researchers and lab work; diagram shown of how potential cancer treatments work. [Entremed researcher Dr. John HOLADAY - says the research is bearing fruit.] [Children's Hospital researcher Judah FOLKMAN (over phone)- describes effectiveness of new drugs in mice.] [Cornell Med Center Dr. Anne MOORE - would call the potential cancer drugs miracles.]
(Studio: Dan Rather) Interview held with CBS medical consultant Dr. Bernadine Healy. [HEALY - explains excitement about new drugs and hurdles drugs go through before FDA (Food and Drug Administration) acceptance.]
- Rather, Dan;
- Roberts, John
Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.
Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:
- You may request a loan of this video by registering on our website and placing an order.
- You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
- If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.
If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.